Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions

NarcolepsyObstructive Sleep ApneaExcessive Daytime SomnolenceExcessive SleepinessPostpartum

Interventions

DRUG

Solriamfetol 150 mg Oral Tablet

Single-dose 150 mg tablet orally administered.

Trial Locations (1)

M3-Wake Research, Inc., Raleigh